Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients
-
Add time:07/20/2019 Source:sciencedirect.com
BackgroundThis series of studies examines the pharmacokinetic/pharmacodynamic interactions between buprenorphine, an opioid partial agonist increasingly used in treatment of opioid dependence, and rifampin, a medication used as a first line treatment for tuberculosis; or rifabutin, an alternative antituberculosis medication.
We also recommend Trading Suppliers and Manufacturers of 25-DESACETYL RIFABUTIN (cas 100324-63-8). Pls Click Website Link as below: cas 100324-63-8 suppliers
Prev:Determination of the rifamycin antibiotics rifabutin, rifampin, rifapentine and their major metabolites in human plasma via simultaneous extraction coupled with LC/MS/MS
Next:Determination of rifabutin in human plasma by high-performance liquid chromatography with ultraviolet detection) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis07/24/2019
- Specific high-performance liquid chromatography assay for determination of rifabutin plasma concentration following Extrelut column extraction07/23/2019
- Determination of rifabutin in human plasma by high-performance liquid chromatography with ultraviolet detection07/22/2019
- Determination of the rifamycin antibiotics rifabutin, rifampin, rifapentine and their major metabolites in human plasma via simultaneous extraction coupled with LC/MS/MS07/21/2019
- Identification of rat urinary metabolites of rifabutin using LC–MSn and LC–HR-MS07/19/2019
